Conditions: Heart Failure With Reduced Ejection Fraction
Interventions: Drug: Metoprolol Succinate; Device: Beta-Blocker Polygenic Score; Device: Illumina Infinium Global Diversity Array with Enhanced Pharmacogenomics (PGx)
Sponsors: University of Michigan; National Heart, Lung, and Blood Institute (NHLBI)
Not yet **RECRUITING NOW**
Source: View full study details on ClinicalTrials.gov
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
